Watch Ticker

InflaRx N.V. Common Stock

Go to InflaRx N.V. Common Stock Website

$0.88

-0.01 (-0.95%)

Live

Previous Close

$0.8884

Day Range

$0.8605 - $0.9242

Previous Day Range

$0.850001 - $0.921

Market Cap

$58.3 million USD

Day Vol.

162217

Previous Day Vol.

96194

Currency

USD

Primary Exchange

Nasdaq

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its recepto...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - InflaRx Announces Outcome of Interim Analysis for Vilobelimab Phase 3 Trial in Pyoderma Gangrenosum

InflaRx announced that the Independent Data Monitoring Committee recommended stopping the Phase 3 trial for vilobelimab in pyoderma gangrenosum due to futility. The company will focus on its oral inhibitor INF904 and consider cost-saving measures.

Related tickers: IFRX.

Read Full Article

N/A - InflaRx Announces Pricing of $30 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

InflaRx N.V. announced the pricing of its public offering of 8,250,000 ordinary shares and 6,750,000 pre-funded warrants at $2.00 per share. The company intends to use the net proceeds to fund the clinical development of its pipeline candidates and for general corporate purposes.

Related tickers: IFRX.

Read Full Article

Trending Tickers

Please sign in to view